Clinical Drug Experience Knowledgebase

Asthma, Aspirin-Induced (Phase 2)

Autoimmune Diseases (Phase 2)

Birth Weight (Phase 4)

Burns (Phase 3)

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Cardiovascular Diseases (Phase 2)

Connective Tissue Diseases (Phase 2)

Constipation (Phase 4)

Drug Overdose (Phase 3)

Ductus Arteriosus, Patent (Phase 4)

Dyslipidemias (Phase 2)

Emergencies (Phase 3)

Fever (Phase 4)

Fibrosis (Phase 2)

Heart Failure (Phase 3)

Hemorrhage (Phase 4)

Hepatorenal Syndrome (Phase 2)

Hypercholesterolemia (Phase 2)

Hypertension (Phase 2)

Hypertension, Portal (Phase 2)

Hyponatremia (Phase 4)

Intracranial Hemorrhages (Phase 4)

Kidney Diseases (Phase 4)

Liver Cirrhosis (Phase 2)

Liver Diseases (Phase 1)

Muscular Dystrophies (Phase 2)

Muscular Dystrophy, Duchenne (Phase 2)

Neoplasms (Phase 2)

Obesity (Phase 4)

Pain, Postoperative (Phase 3)

Pathologic Processes (Phase 2)

Pelvic Pain (Phase 4)

Recurrence (Phase 2)

Respiration Disorders (Phase 2)

Respiratory Tract Diseases (Phase 2)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Limited (Phase 2)

Scleroderma, Localized (Phase 2)

Scleroderma, Systemic (Phase 2)

Sclerosis (Phase 2)

Skin Diseases (Phase 2)

Syndrome (Phase 2)